knowcompoundscrocin-1
Specimen compound organic compound
Crocin-1
A diester that is crocetin in which both of the carboxy groups have been converted to their gentiobiosyl esters.
Continue
It is one of the water-soluble yellow-red pigments of saffron and is used as a spice for flavouring and colouring food. Note that in India, the term 'Crocin' is also used by GlaxoSmithKline as a brand-name for paracetamol.”
- Formula
- C44H64O24
- Molar mass
- 976.972 g/mol
- ChEBI
- CHEBI:79068
- InChIKey
- SEBIKDIMAPSUBY-RTJKDTQDSA-N
↑ raised 1 finding in 1 endpoint · ↓ lowered 9 in 8 · – no difference found 4 in 4
01 · the evidence, ordered
What the evidence says
- Strong
- 0
- Moderate
- 3
- Limited
- 0
- Very limited
- 11
- Insufficient
- 0
Crocin-1
Most findings
- C-reactive protein concentration×2
- Triglycerides×2
- Beck Depression Inventory (BDI) total score×1
- Pittsburgh Sleep Quality Index global score×1
Show the remaining 8Show the first 4
- Fasting blood glucose×1
- HDL cholesterol×1
- Interleukin-6 concentration×1
- LDL cholesterol×1
- Malondialdehyde (circulating)×1
- Total antioxidant capacity×1
- Total cholesterol (TC)×1
- Tumour necrosis factor alpha concentration×1
36 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
- Triglyceridescontested
- Beck Depression Inventory (BDI) total score
- Pittsburgh Sleep Quality Index global score
- C-reactive protein concentration
- Fasting blood glucose
- HDL cholesterol
- Interleukin-6 concentration
- LDL cholesterol
- Malondialdehyde (circulating)
- Total antioxidant capacity
- Total cholesterol (TC)
- Tumour necrosis factor alpha concentration
Show the remaining 4Show the first 8
02 · contested · 1 endpoint
Where the findings disagree
012 findings
Triglycerides
03 · findings
What crocin-1 moved, and by how much
- MD mean difference · SMD standardised mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
12 of 14 shown
- Pittsburgh Sleep Quality Index global scoreMoved: lowersEvidence: ModeratePaper: PMID 307957852019
- Who
- Patients under methadone maintenance treatment (methadone in both arms); crocin 30 mg/day versus placebo
- Dose studied
- 30 mg/day crocin (15 mg twice daily)
After 8-week intervention, crocin significantly decreased Beck Depression Inventory (b - 6.66; 95% CI, - 9.88, - 3.45; P < 0.0001), Beck Anxiety Inventory (b - 4.35; 95% CI, - 5.94, - 2.75; P < 0.0001), general health questionnaire (b - 4.45; 95% CI, - 7.68, - 1.22; P = 0.008) and Pittsburgh Sleep Quality Index (b - 2.73; 95% CI, - 3.74, - 1.73; P < 0.0001) in patients under MMT, compared with the placebo.”
Quoted verbatim from The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial.RCT · 8 weeksPermalink - TriglyceridescontestedMoved: lowersEvidence: ModeratePaper: PMID 362090912022
- Who
- Adults with type 2 diabetes and microalbuminuria on routine antidiabetic, antihypertensive and lipid-lowering care; crocin 15 mg/day versus placebo
- Dose studied
- 15 mg crocin tablet daily
As listed in Table 2, comparison of the crocin and placebo groups for changes in variables (before- after) showed that mean serum TG levels decreased significantly in the crocin group compared with the increasing values in the placebo group (P-Value = 0.03).”
Quoted verbatim from Evaluation of therapeutic effects of crocin in attenuating the progression of diabetic nephropathy: a preliminary randomized triple-blind placebo-controlled trial.RCT · 3 monthsPermalink - Beck Depression Inventory (BDI) total scoreMoved: lowersEvidence: ModeratePaper: PMID 307957852019
- Who
- Patients under methadone maintenance treatment (methadone in both arms); crocin 30 mg/day versus placebo
- Dose studied
- 30 mg/day crocin (15 mg twice daily)
After 8-week intervention, crocin significantly decreased Beck Depression Inventory (b - 6.66; 95% CI, - 9.88, - 3.45; P < 0.0001), Beck Anxiety Inventory (b - 4.35; 95% CI, - 5.94, - 2.75; P < 0.0001), general health questionnaire (b - 4.45; 95% CI, - 7.68, - 1.22; P = 0.008) and Pittsburgh Sleep Quality Index (b - 2.73; 95% CI, - 3.74, - 1.73; P < 0.0001) in patients under MMT, compared with the placebo.”
Quoted verbatim from The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial.RCT · 8 weeksPermalink - Fasting blood glucoseMoved: lowersEffect, as reportedMD−6.52[−11.96 to −1.08]Evidence: Very limitedPaper: PMID 329517482020
- Who
- Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
- Dose studied
- not reported
Results of the pooled random-effect size analysis showed just a significant decreasing effect of crocin supplementation on FBG (WMD: -6.52 mg/l, 95 % CI, -11.96, -1.08; p = 0.019) and TC (WMD: -4.64 mg/l, 95 % CI, -8.19, -1.09; p = 0.010).”
Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink - Total cholesterol (TC)Moved: lowersEffect, as reportedMD−4.64[−8.19 to −1.09]Evidence: Very limitedPaper: PMID 329517482020
- Who
- Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
- Dose studied
- not reported
Results of the pooled random-effect size analysis showed just a significant decreasing effect of crocin supplementation on FBG (WMD: -6.52 mg/l, 95 % CI, -11.96, -1.08; p = 0.019) and TC (WMD: -4.64 mg/l, 95 % CI, -8.19, -1.09; p = 0.010).”
Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink - LDL cholesterolMoved: no difference foundEvidence: Very limitedPaper: PMID 329517482020
- Who
- Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
- Dose studied
- not reported
Crocin supplements did not have any significant effect on serum TG (p = 0.144) levels, LDL-C (p = 0.161), and HDL-C (p = 0.872) levels.”
Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink - TriglyceridescontestedMoved: no difference foundEvidence: Very limitedPaper: PMID 329517482020
- Who
- Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
- Dose studied
- not reported
Crocin supplements did not have any significant effect on serum TG (p = 0.144) levels, LDL-C (p = 0.161), and HDL-C (p = 0.872) levels.”
Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink - C-reactive protein concentrationMoved: lowersEvidence: Very limitedreplicated ×1Paper: PMID 383068882024
- Who
- Patients with multiple sclerosis; crocin 15 mg twice daily (30 mg/day) versus placebo
- Dose studied
- 15 mg crocin tablet twice daily (30 mg/day)
The data analysis using ANCOVA showed that supplementation with crocin for 8 weeks significantly lowered hs-CRP levels (p-value= 0.01).”
Quoted verbatim from Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial.RCT · 8 weeksPermalink - C-reactive protein concentrationMoved: lowersEffect, as reportedSMD−0.5[−0.86 to −0.13]Evidence: Very limitedreplicated ×1Paper: PMID 396326022025
- Who
- Adults supplemented with crocin in pooled randomised clinical trials
- Dose studied
- not reported
Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”
Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink - Tumour necrosis factor alpha concentrationMoved: lowersEffect, as reportedSMD−1.96[−2.72 to −1.19]Evidence: Very limitedPaper: PMID 396326022025
- Who
- Adults supplemented with crocin in pooled randomised clinical trials
- Dose studied
- not reported
Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”
Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink - Total antioxidant capacityMoved: raisesEffect, as reportedSMD1.48[0.52 to 2.43]Evidence: Very limitedPaper: PMID 396326022025
- Who
- Adults supplemented with crocin in pooled randomised clinical trials
- Dose studied
- not reported
Also, crocin supplementation led to a significant increase in total antioxidant capacity (TAC) (SMD: 1.48; 95%CI: 0.52 to 2.43; p = 0.002).”
Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink - Interleukin-6 concentrationMoved: lowersEffect, as reportedSMD−3.52[−6.84 to −0.2]Evidence: Very limitedPaper: PMID 396326022025
- Who
- Adults supplemented with crocin in pooled randomised clinical trials
- Dose studied
- not reported
Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”
Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink
No row matches these filters.
No dose is advised.
- MD mean difference · SMD standardised mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
04 · identity
Structure
- Charge
- 0
- 3D model
- None at PubChem
- SMILES
- CC(/C=C/C=C(C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)=CC=CC=C(C)C=CC=C(/C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O
What the reference databases state
- Reactions · Rhea
- 1reaction
1Reaction
06 · on the label · 274 products
Labelled products
Source: NIH DSLD · Ingredient: crocin-1 · 274 products · Declared amount per serving: 1.5–1,156 mg
212 labels state an amount62 do not
- Ab Cuts Sleek & LeanThermo Rise 02100 mgper 2 softgelsDSLD:23446
- AceworkzSaffron Extract88.5 mgper 1 veggie capsuleDSLD:258789
- AddrenaNo-Stim352 mgper 2 tabletsDSLD:206848
- Advanced Nutrition by ZahlerChildCalm Fruit Punch FlavorSaffron Stigma Extract28 mgper 2 tabletsDSLD:260021
- Advanced Nutrition by ZahlerChildCalm Fruit Punch FlavorSaffron Stigma Extract28 mgper 1 tabletDSLD:313722
- Advanced Nutrition by ZahlerMasterMindSaffron Stigma Extract28 mgper 1 capsuleDSLD:316633
- Advanced Nutrition by ZahlerTeen FocusSaffron Extract28 mgper 1 capsuleDSLD:301148
- Allergy Research GroupMood Support15 mgper 1 capsuleDSLD:233304
- AmbrosiaRitual-PMSaffron Stigma Extract28 mgper 2 capsulesDSLD:334103
- AOR Advanced Orthomolecular Research AdvancedSaffron30 mgper 1 capsuleDSLD:214874
- Approved ScienceSaffron +BioperineCrocins · Standardized to 3% Crocin, 2% Safranal30 mgper 2 capsulesDSLD:313341
- ArbonneFeelFit Watermelon Kiwi FlavorCrocus sativus Flower Extract, Powder6 mgper 3.43 gDSLD:335883
Show the remaining 262Show the first 12
Label record: NIH Office of Dietary Supplements · CC0
07 · the record
Sources
47
papers screened for crocin-1
- admitted
- 5
- read and discarded
- 7
- not read yet
- 35
Sources cited
5 papers · 14 findings
Show every paper citedHide the papers cited
Other names · 20
alpha-crocin · bis-(beta-D-gentiobiosyl) crocetin · C.I. 75100 · Crocetin A · crocetin di-β-D-gentiobiose ester · crocetin di-gentiobiose ester · crocetin digentiobioside · Crocin · Crocin 1 · Crocin A · crocine · Digentiobiosyl-8,8'-diapocarotene-8,8'-dioate · Digentiobiosyl-Crocetin · Gardenia Yellow · Natural red 1 · Natural yellow 19 · Natural yellow 6 · Saffron · trans-crocetin bis(β-D-gentiobiosyl) ester
systematic · bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate